American Scientific Resources Announces Contract with Amerinet, Inc.

American Scientific Resources, Inc. (OTCBB: ASFX) (“American Scientific”) today announced it has signed a three year contract with Amerinet Inc., a leading national healthcare solutions organization that leverages the purchasing power of healthcare businesses to obtain discounts from vendors based on the collective buying power of the General Purchasing Organization (GPO) members. The initial product to be introduced through this agreement is the VeraTemp+ Non-Contact thermometer. The contract with Amerinet group purchasing organization represents a license to solicit business directly from its more than 49,000 members. The Amerinet contract raises the level of product awareness to more than 49,000 clinics, hospitals, long terms care facilities, ambulatory surgery centers and other healthcare providers and enables American Scientific Resources to sell directly to them.

The VeraTemp+ thermometer uses the most advanced thermometry technology to record an individual’s temperature without touching the patient’s skin by simply pointing the device at the forehead and pressing a button. The VeraTemp+ is 100% hygienic and requires no probe covers; saving unnecessary expense and waste. Moreover, the VeraTemp+ helps Infection Control initiatives by helping to eliminate the risk of cross contamination between patients.

Marc Massoglia, Senior Vice President of Sales of American Scientific stated that, “our target is to convert users of the Exergen temporal scanner to the VeraTemp+. With infection control being an important focus of our customers, the VeraTemp+ is clearly superior because it is 100% non-contact and hygienic.” Massoglia continued, “We will begin soliciting business directly with the member clinics, hospitals and other healthcare providers in November. We recognize that the process will take some time but this is a significant step in expanding our domestic clinical market."

"Potential new sales in the clinical markets from GPO customers and national accounts lead us to be optimistic about the strengthening profitability of the company," stated Dr. Christopher F. Tirotta, Chief Executive Officer and Chairman of American Scientific Resources, Inc.

About Amerinet

As a leading national healthcare solutions organization, Amerinet collaborates with acute and non-acute care providers to create and deliver unique solutions through performance improvement resources, guidance and ongoing support. With better product standardization and utilization, new financial tools beyond contracting and alliances that help lower costs, raise revenue and champion quality, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about how Amerinet can help you successfully navigate the future of healthcare reform, visit www.amerinet-gpo.com.

About American Scientific Resources, Inc.

American Scientific Resources, Inc. is a purpose-driven consumer product manufacturer specializing in the clinical, home healthcare, infant and juvenile product industries. The Company sources and designs innovative health and safety products, developing advanced technology and intellectual property. Products are distributed through established relationships in-house and through an ever growing network of leading global healthcare distributors and retailers. Brands under the American Scientific Resources umbrella include Kidz-Med, Disintegrator Plus, VeraTemp and Mebby.

For more information, visit the corporate web site at www.americansci.com, www.kidzmed.com and www.disintegratorplus.com

Safe Harbor

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

American Scientific Reso... (CE) (USOTC:ASFX)
過去株価チャート
から 11 2024 まで 12 2024